C

Cyclacel Pharmaceuticals
D

CYCC

0.25200
USD
0.00
(1.16%)
مغلق
حجم التداول
2,706
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
52,248,770
أصول ذات صلة
A
ARAY
0.01000
(0.74%)
1.36000 USD
A
AXSM
-0.050
(-0.04%)
112.190 USD
B
BCLI
0.07000
(6.03%)
1.23000 USD
C
CRBP
0.26000
(3.45%)
7.79000 USD
C
CYCCP
-0.36000
(-6.91%)
4.85000 USD
J
JAGX
0.970
(8.16%)
12.860 USD
K
KZIA
0.05000
(1.32%)
3.85000 USD
P
PAVM
-0.03000
(-3.66%)
0.79000 USD
V
VKTX
0.775
(2.71%)
29.360 USD
المزيد
الأخبار المقالات

العنوان: Cyclacel Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.